Brief: New Indication Approved For Guerbet’s Lipiodol Ultra Fluid
Sept 11 (Reuters) - GUERBET SA GRBT.PA :
* NEW INDICATION APPROVED FOR GUERBET’S LIPIODOL ULTRA FLUID IN BELGIUM, IRELAND, PORTUGAL,
HONG-KONG AND THE PHILIPPINES
* LIPIODOL ULTRA FLUID NOW APPROVED FOR CONVENTIONAL TRANS-ARTERIAL CHEMOEMBOLIZATION OF
INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA
Source text: https://bit.ly/2CLjHbw
Further company coverage: GRBT.PA
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Guerbet SA
See all newsBrief: Guerbet Revenue At 30 September 2026 Of EUR 573.8 Million
Corrected: French medical imaging firm Guerbet's 9M revenue slips on China sales drop
French medical imaging firm Guerbet H1 EBITDA margin falls on Raleigh site costs
Brief: Guerbet H1 EBITDA €30.6 Mln
French and Benelux stocks-Factors to watch